SCHEMBL23833715

SCHEMBL23833715

O=C1C(Cl)=C(Cl)C(=O)C(Cl)(Cl)C1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11876860 0.68 KDM4E (0.30)
SCHEMBL1668936 0.65
SCHEMBL28647953 0.62 CES2 (0.38)
SCHEMBL21443828 0.62 S100A4 (0.43)
SCHEMBL11418036 0.62 CES2 (0.38)
SCHEMBL2637337 0.60 ALDH1A1 (0.56)
SCHEMBL10491545 0.57
SCHEMBL6758482 0.57
SCHEMBL9615320 0.54 MAP3K14 (0.35)
SCHEMBL15693706 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250222053-A1 COMPOSITIONS COMPRISING CANNABIS AND MUSHROOM EXTRACTS, AND USES THEREOF COOKIES CREATIVE CONSULTING & PROMOTIONS, INC. 2025-07-10 US disclosed
US-12290542-B2 Compositions comprising cannabis and mushroom extracts, and uses thereof COOKIES CREATIVE CONSULTING & PROMOTIONS, INC. (US) 2025-05-06 US disclosed
US-20240252569-A1 COMPOSITIONS COMPRISING CANNABIS AND MUSHROOM EXTRACTS, AND USES THEREOF COOKIES CREATIVE CONSULTING & PROMOTIONS, INC. 2024-08-01 US disclosed
US-11951142-B2 Compositions comprising Cannabis and mushroom extracts, and uses thereof COOKIES CREATIVE CONSULTING & PROMOTIONS, INC. (US) 2024-04-09 US disclosed
EP-4271367-A1 COMPOSITIONS COMPRISING CANNABIS AND MUSHROOM EXTRACTS, AND USES THEREOF Cookies Creative Consulting & Promotions, Inc. (US) 2023-11-08 EP disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
EP-4121029-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF Amathus Therapeutics, Inc. (US) 2023-01-25 EP disclosed
WO-2022147270-A1 COMPOSITIONS COMPRISING CANNABIS AND MUSHROOM EXTRACTS, AND USES THEREOF COOKIES CREATIVE CONSULTING & PROMOTIONS, INC. (US) 2022-07-07 WO disclosed
WO-2021188880-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed